1) Dingxuan Capsule
定眩胶囊
1.
The Effect of Dingxuan Capsule to the Activity of Brain Tissue SOD and the Content of Serum NO of Vertebro-basilar Artery Insufficiency Rat;
定眩胶囊对椎-基底动脉供血不足大鼠脑组织SOD活性和血清NO含量的影响
2) Gegen Dingxuan Capsules
葛根定眩胶囊
1.
Quality Standard for Gegen Dingxuan Capsules;
葛根定眩胶囊的质量标准
3) Zhengxuan capsule
正眩胶囊
1.
OBJECTIVE:To assess the clinical effects of Zhengxuan capsule in treating vertigo due to qi insufficiency, blood stasis, and deficiency of the liver and kidney.
目的 探讨正眩胶囊治疗气虚血瘀、肝肾不足型眩晕病的临床疗效。
4) Qingxuan Jiangya Capsules
清眩降压胶囊
1.
Determination of Sinapine in Qingxuan Jiangya Capsules;
RP—HPLC法测定清眩降压胶囊中芥子碱的含量
5) Dingxin capsule
定心胶囊
1.
Objective:Exploring effection about right atrial fibrillation rat atrial muscle Ca2+-ATPase enzyme and protein Connexin 40(Cx40) gene expression by Dingxin capsule s intervene,and reveal mechanism of the prevention and treatment of atrial fibrillation by Dingxin capsule which has benefiting QI,nourishing YIN and activing Blood tranditional Chinese medicine.
目的:探讨中药定心胶囊对房颤大鼠心房肌组织Ca2+-ATP酶及缝隙连接蛋白40(Cx40)基因表达的影响,揭示益气养阴活血中药定心胶囊预防和治疗房颤的作用机理。
2.
Objective:To explore the expression of serum metalloproteinase-9(MMP-9)in Rats during the Atrial fibrillation(AF)and the influence of Dingxin capsule for Recuperation on it.
将造模成功的大鼠设模型组、正常对照组、西药对照组和定心胶囊治疗组。
3.
Objective:The aim of this study is to develop the effective therapy for atrial fibrillation(AF),and study the mechanisms of Dingxin capsule.
目的:探讨定心胶囊对房颤大鼠P-选择素的作用机制,研究开发中药治疗房颤及预防房颤后血栓。
6) Dingkun capsule
定坤胶囊
1.
Dingkun capsule and tablet are processed from Dingkun pill, which is composed of 27 kinds of Traditional Chinese Medicine.
定坤胶囊和片剂是经改变定坤丸的制备工艺加工制成，处方由西洋参、鹿茸、白芍、黄芩等共二十七味中药材组成。
补充资料：抗眩定
分子式：C8H12N2·2HCl
分子量：暂无
CAS号：5579-84-0
性质：白色或类白色结晶或结晶性粉末。
制备方法：暂无
用途：用于治疗内耳眩晕症（即美尼尔综合症）、脑动脉硬化、脑供血不足以及高血压引起的眩晕、呕吐与耳鸣。
分子量：暂无
CAS号：5579-84-0
性质：白色或类白色结晶或结晶性粉末。
制备方法：暂无
用途：用于治疗内耳眩晕症（即美尼尔综合症）、脑动脉硬化、脑供血不足以及高血压引起的眩晕、呕吐与耳鸣。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条